Suppr超能文献

前瞻性研究无射线透视激光球囊肺静脉隔离治疗心房颤动。

Prospective study of zero-fluoroscopy laser balloon pulmonary vein isolation for the management of atrial fibrillation.

机构信息

Section of Electrophysiology, Division of Cardiology, Rush University Medical Center, 1717 W, Congress Parkway, Kellogg, Suite 320, Chicago, IL, 60612, USA.

Cardiac Electrophysiology, Florida Heart Rhythm Specialists, Fort Lauderdale, FL, USA.

出版信息

J Interv Card Electrophysiol. 2023 Oct;66(7):1669-1677. doi: 10.1007/s10840-023-01477-0. Epub 2023 Feb 4.

Abstract

BACKGROUND

In recent years, there has been increased focus on the development of safe and effective strategies to minimize and ultimately eliminate fluoroscopy use in the electrophysiology lab due to the inherent risks to patients and staff associated with this imaging source. However, studies examining these innovative fluoroless strategies for pulmonary vein isolation (PVI) using catheters without direct 3D mapping system integration are lacking. We sought to develop a method to perform zero-fluoroscopy laser balloon PVI for patients with atrial fibrillation (AF), and to test the safety and efficacy of this approach.

METHODS

We developed a standardized method for performing PVI using the X3 laser balloon (LB) system, 3-dimensional electroanatomic mapping (3D-EAM) and intracardiac echocardiography (ICE) in a cohort of patients with symptomatic AF. The primary endpoint of the study was the ability to perform PVI without the use of fluoroscopy. Secondary outcomes were rate of successful transseptal puncture on first attempt, first pass isolation of target PVs, mean procedural time, active laser time to achieve PVI, need for use of supplemental energy sources, and procedural complication rates.

RESULTS

Two hundred consecutive patients undergoing PVI were recruited in the study. In the zero-fluoroscopy group, LB PVI was successfully performed in 100% of participants (n = 100) without the need for fluoroscopy. Transseptal access was achieved in 100% of cases on the first attempt. Successful first pass PVI was achieved in 360 of the 387 pulmonary veins attempted (93%). Mean procedural time was 68.2 ± 16.2 min in the zero-fluoroscopy group versus 67.5 ± 17.0 min in the conventional fluoroscopy group. PVI was able to be achieved in 100% of cases in both groups without need for use of supplemental energy sources. In the zero-fluoroscopy group there were minimal complications, with 3% of all cases having groin complications and 1 patient with a pericardial effusion noted post-procedure which was managed conservatively.

CONCLUSIONS

We demonstrated that successful zero-fluoroscopy LB PVI could be performed at a single high-volume center by experienced operators in an effective manner, without significant complications.

摘要

背景

近年来,由于与这种成像源相关的患者和工作人员固有的风险,人们越来越关注开发安全有效的策略来尽量减少并最终消除电生理实验室中透视的使用。然而,缺乏使用没有直接 3D 映射系统集成的导管检查这些创新的无荧光策略在肺静脉隔离(PVI)中的研究。我们试图为患有心房颤动(AF)的患者开发一种执行零透视激光球囊 PVI 的方法,并测试这种方法的安全性和有效性。

方法

我们开发了一种使用 X3 激光球囊(LB)系统、三维电解剖图(3D-EAM)和心内超声(ICE)在一组有症状的 AF 患者中进行 PVI 的标准化方法。该研究的主要终点是能够在不使用透视的情况下进行 PVI。次要结果是首次尝试经皮穿刺的成功率、目标 PVs 的初次隔离率、平均手术时间、达到 PVI 的主动激光时间、需要使用补充能源的情况以及手术并发症发生率。

结果

本研究共纳入 200 例接受 PVI 的连续患者。在无透视组中,100%(n=100)的参与者成功地进行了 LB PVI,无需透视。所有情况下的经皮穿刺均在首次尝试时完成。在尝试的 387 个肺静脉中有 360 个(93%)成功地实现了初次隔离。无透视组的平均手术时间为 68.2±16.2 分钟,常规透视组为 67.5±17.0 分钟。两组均无需使用补充能源即可 100%地实现 PVI。在无透视组中,并发症很少,所有病例中有 3%的腹股沟并发症,1 例患者术后出现心包积液,经保守治疗后得到控制。

结论

我们证明,有经验的操作人员可以在单个高容量中心以有效的方式成功地进行无透视 LB PVI,且无明显并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验